A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)

NCT01275170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Disease

Interventions

DRUG: MK-7655
DRUG: Imipenem + Cilastatin
DRUG: Caffeine
DRUG: Midazolam
DRUG: Omeprazole

Sponsor

Merck Sharp & Dohme LLC